In vitro generation of cd4+cd25+ regulatory cells from murine naive t cells

Nature Protocols

Volumn 2, Issue 7, 2007, Pages 1789-1794

  Fantini, Massimo C ^a   Dominitzki, Sabine ^b   Rizzo, Angelo ^a   Neurath, Markus F ^b   Becker, Christoph ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; GENETICS; IMMUNOLOGY; MOUSE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD4; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 34548564632     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2007.258     Document Type: Article

References (15)

1. Sakaguchi, S.: Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8-27 (2006).
2. Asano, M., Toda, M., Sakaguchi, N. and Sakaguchi, S.: Autoimmune disease as a consequence ofdevelopmentalabnormality ofaT cell subpopulation. J. Exp. Med. 184, 387-396 (1996).
3. Hori, S., Nomura, T. and Sakaguchi, S.: Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
4. Bennett, C.L.: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations ofFOXP3. Nat. Genet. 27, 20-21 (2001).
5. Godfrey, V.L., Wilkinson, J.E. and Russell, L.B.: X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138, 1379-1387 (1991).
6. Mottet, C., uhlig, H.H. and Powrie, F.: Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170, 3939-3943 (2003).
7. Kohm, A.P., Carpentier, P.A., Anger, H.A. and Miller, S.D.: Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712-4716 (2002).
8. Chen, W.: Conversion of peripheral CD4+CD25— naive T cells to CD4+CD25+ regulatoryT cells by TGF-beta induction oftranscription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
9. Fantini, M.C.: Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25— T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153 (2004).
10. Fantini, M.C.: Transforming growth factor beta induced Foxp3+ regulatory T cells suppress Th1-mediated experimental colitis. Gut 55, 604-606 (2006).
11. Bettelli, E.: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).
12. Mangan, P.R.: Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231-234 (2006).
13. Zelenay, S.: Foxp3+ CD25— CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. USA 102, 4091-4096 (2005).
14. Davidson, T.S., DiPaolo, R.J., Andersson, J. and Shevach, E.M.: Cutting Edge:IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 178, 4022-4026 (2007).
15. Zheng, S.G., Wang, J., Wang, P., Gray, J.D. and Horwitz, D.A.: IL-2 is essential for TGF-beta to convert naive CD4+CD25— cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J. Immunol. 178, 2018-2027 (2007).